LADENBURG THALMANN FINANCIAL SERVICES INC. - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 26 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$3,000
-93.5%
4,000
-82.6%
0.00%
Q2 2018$46,0000.0%23,0000.0%0.00%
Q1 2018$46,000
-22.0%
23,0000.0%0.00%
-100.0%
Q4 2017$59,000
+78.8%
23,0000.0%0.00%
Q3 2017$33,000
+6.5%
23,0000.0%0.00%
Q2 2017$31,00023,0000.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Puissance Capital Management LP 8,298,755$17,261,00014.88%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 15,138,486$31,488,0002.58%
VHCP Management II, LLC 4,149,378$8,631,0002.08%
Boxer Capital, LLC 1,857,143$3,863,0000.41%
Telemetry Investments, L.L.C. 199,000$414,0000.16%
EAM Investors, LLC 232,290$483,0000.08%
DRW Securities, LLC 70,000$146,0000.01%
Renaissance Technologies 1,032,900$2,148,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 23,000$48,0000.00%
STATE STREET CORP 13,800$29,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders